Acupuncture as anticancer treatment?

Paulina Frączek, Aneta Kilian-Kita, Mirosława Püsküllüoglu, Krzysztof Krzemieniecki
Author Information
  1. Paulina Frączek: Department of Oncology Jagiellonian University, Krakow, Poland.
  2. Aneta Kilian-Kita: Department of Oncology Jagiellonian University, Krakow, Poland.
  3. Mirosława Püsküllüoglu: Department of Oncology Jagiellonian University, Krakow, Poland.
  4. Krzysztof Krzemieniecki: Department of Oncology Jagiellonian University, Krakow, Poland.

Abstract

The mystery of Traditional Chinese Medicine has been attracting people for years. Acupuncture, ranked among the most common services of Complementary and Alternative Medicine, has recently gained a lot of interest in the scientific world. Contemporary researchers have been continuously trying to shed light on its possible mechanism of action in human organism. Numerous studies pertaining to acupuncture's application in cancer symptoms or treatment-related side effects management have already been published. Moreover, since the modern idea of acupuncture's immunomodulating effect seems to be promising, scientists have propounded a concept of its potential application as part of direct anti-tumor therapy. In our previous study we summarized possible use of acupuncture in management of cancer symptoms and treatment-related ailments, such as chemotherapy-induced nausea and vomiting, pain, xerostomia, vasomotor symptoms, neutropenia, fatigue, anxiety, insomnia, lymphoedema after mastectomy and peripheral neuropathy. This article reviews the studies concerning acupuncture as a possible tool in modern anticancer treatment.

Keywords

References

Zhongguo Zhen Jiu. 2008 Aug;28(8):607-9 [PMID: 18767588]
J Immunol. 2002 Feb 15;168(4):1831-9 [PMID: 11823516]
BMC Complement Altern Med. 2014 Jun 25;14:201 [PMID: 24965334]
Neuroscience. 2006 Jul 21;140(4):1169-76 [PMID: 16730915]
Evid Based Complement Alternat Med. 2011;2011:481625 [PMID: 21785626]
Ann Oncol. 2005 Apr;16(4):655-63 [PMID: 15699021]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996 Mar;16(3):139-41 [PMID: 9208533]
J Biol Chem. 1999 Feb 19;274(8):4939-46 [PMID: 9988737]
BMC Complement Altern Med. 2013 Dec 17;13:362 [PMID: 24344728]
Contemp Oncol (Pozn). 2016;20(2):119-23 [PMID: 27358589]
Ann Intern Med. 2001 Aug 21;135(4):262-8 [PMID: 11511141]
Zhen Ci Yan Jiu. 1993;18(3):174-7 [PMID: 7923712]
Exp Hematol. 2001 Oct;29(10):1157-68 [PMID: 11602317]
Int Immunopharmacol. 2001 Aug;1(8):1513-24 [PMID: 11515816]
J Neuroimmunol. 1998 Oct 1;90(2):176-86 [PMID: 9817445]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994 Sep;14(9):537-9 [PMID: 7866002]
Annu Rev Immunol. 2006;24:257-86 [PMID: 16551250]
Zhonghua Wai Ke Za Zhi. 2001 Oct;39(10):756-8 [PMID: 16201187]
Expert Opin Biol Ther. 2005 Oct;5(10):1303-15 [PMID: 16197336]
J Immunol. 2011 Sep 1;187(5):2775-82 [PMID: 21804019]
J Immunol. 1996 Aug 1;157(3):1117-26 [PMID: 8757616]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Oct;15(10):615-7 [PMID: 8704430]
Nitric Oxide. 2007 Sep;17(2):60-8 [PMID: 17613264]
JAMA. 1998 Nov 4;280(17):1518-24 [PMID: 9809733]
Evid Based Complement Alternat Med. 2007 Dec;4(4):447-53 [PMID: 18227912]
Nat Rev Drug Discov. 2002 Mar;1(3):229-37 [PMID: 12120507]
Int J Oncol. 2010 Dec;37(6):1361-78 [PMID: 21042704]
Jpn J Physiol. 1997 Apr;47(2):173-8 [PMID: 9201546]
Zhen Ci Yan Jiu. 2007;32(3):153-7 [PMID: 17691570]
Zhongguo Zhen Jiu. 2010 Jan;30(1):10-2 [PMID: 20353106]
Int Rev Immunol. 2001 Jun;20(3-4):415-37 [PMID: 11878511]
Science. 1994 Sep 9;265(5178):1573-7 [PMID: 8079170]
J Leukoc Biol. 2005 Mar;77(3):408-13 [PMID: 15604121]
J Exp Med. 1998 Jun 15;187(12):2065-72 [PMID: 9625766]
Evid Based Complement Alternat Med. 2013;2013:387169 [PMID: 24228059]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Mar;21(3):174-6 [PMID: 12577330]
Cancer. 2009 May 15;115(10 Suppl):2298-305 [PMID: 19402060]
J Altern Complement Med. 2013 Nov;19(11):911-5 [PMID: 23536964]
Acupunct Electrother Res. 2007;32(1-2):31-70 [PMID: 18077937]

Word Cloud

Similar Articles

Cited By